Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

22.15
Delayed Data
As of Mar 27
 +0.15 / +0.68%
Today’s Change
17.92
Today|||52-Week Range
36.83
-36.35%
Year-to-Date
No recent news for AMAG Pharmaceuticals Inc.

Today’s Trading

Previous close22.00
Today’s open21.90
Day’s range21.65 - 22.30
Volume812,036
Average volume (3 months)1,222,806
Market cap$760.6M
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-107.53%
Earnings growth (this year)+7.35%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+27.21%
P/E ratioNM
Price/Sales2.25
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...+0.36+2.01%
JNCEJounce Therapeutics ...-0.59-2.31%
MYOVMyovant Sciences Ltd+0.35+3.04%
NDRMNeuroderm Ltd+1.10+4.25%
Data as of 03/27/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$532.1M
Annual profit (last year)-$2.5M
Net profit margin-0.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs